TG Therapeutics | TGTX - Devedores Comerciais

Preço das Ações
34.06
Mudança Diária
0.48 1.43%
Mensal
2.53%
Anual
-24.93%
Q2 Previsão
35.84




Devedores Comerciais Alterar Data
AbbVie USD 12.59B 180M 2025-12
Alaunos Therapeutics USD 2K 0 2025-06
Amgen USD 9.57B 1.08B 2025-12
Ardelyx USD 71.85M 4.76M 2025-12
Arrowhead Research USD 218.87M 212.05M 2025-12
Bayer EUR 14.19B 720M 2025-12
Biogen USD 1.79B 76.6M 2026-03
Corcept Therapeutics USD 59.79M 9.84M 2025-12
Curis USD 2.55M 400K 2024-06
Gilead Sciences USD 4.91B 182M 2025-12
J&J USD 21.33B 3.72B 2025-12
Karyopharm Therapeutics USD 26.18M 5.6M 2025-12
Novartis USD 12.29B 3.3B 2025-12
Novavax USD 106.45M 72.27M 2025-12
PTC Therapeutics USD 181.62M 21.45M 2025-12
Puma Biotechnology USD 28.1M 3.52M 2024-06
Regeneron Pharmaceuticals USD 5.73B 10.1M 2026-03
Roche Holding CHF 11.9B 460M 2025-12
TG Therapeutics USD 265.38M 33.86M 2025-09
Verastem USD 9.01M 8.81M 2025-12
Vertex Pharmaceuticals USD 2.05B 106.4M 2025-12